|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||1.4300 - 1.4827|
|52 Week Range||0.3800 - 4.5000|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
NeuroMetrix Inc (NASDAQ:NURO), a medical equipment company based in United States, saw a double-digit share price rise of over 10% in the past couple of months on the NasdaqCM. AsRead More...
NeuroMetrix Inc (NASDAQ:NURO) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017.
Shares of Neurometrix Inc (NASDAQ:NURO) rocketed more than 60% higher at one point Wednesday morning after the healthcare company announced a new collaboration with GlaxoSmithKline plc (ADR) (NYSE:GSK), involving Quell, the company's over-the-counter, 100% drug free chronic pain relief wearable. Specifically, GSK Consumer Healthcare acquires exclusive ownership of Quell technology for markets outside the U.S. Neurometrix will receive a payment of $5 million for the assets relating to Quell technology for markets outside the U.S and up to $21.5 million, upon the achievement of certain development and commercialization milestones. Investors will need to wait to see more precise details, but for a penny stock such as Neurometrix, this is pretty amazing no matter the exact dollar amount.
Shares of NeuroMetrix Inc. rocketed 78% toward a 7-month high in active premarket trade Wednesday, after chronic pain treatments company announced a collaboration with GlaxoSmithLine PLC involving NeuroMetrix's ...
NeuroMetrix Inc (NASDAQ:NURO), a USD$3.90M small-cap, is a healthcare company operating in an industry, which faces key trends such as rising demand fuelled by an aging population and the growingRead More...
NeuroMetrix Inc (NASDAQ:NURO), a healthcare equipment and supplies company based in United States, saw significant share price volatility over the past couple of months on the NasdaqCM, rising to theRead More...
If you are a shareholder in NeuroMetrix Inc’s (NASDAQ:NURO), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of your portfolioRead More...
Categories: Yahoo FinanceGet free summary analysis NeuroMetrix, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of NeuroMetrix, Inc. – Medtronic plc (MDT-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 4.31 million, Net Earnings of USD -3.23 million. Gross margins ... Read more (Read more...)